Tanacetum huronense (Lake Huron tansy), which is native to the upper Midwest region of USA and Canada, was examined for the presence of anticancer compounds using an in vitro human tumor cell proliferation inhibition assay, with glioblastoma derived cell line U-87 MG. Bioassay-directed purification of the ethyl acetate extract of the aerial portion of this plant identified six active sesquiterpenoid lactones (1-6). Among these, compounds 5 and 6 are new structural analogs. One of the most abundant isolates, tanacin (4), exhibited the greatest inhibition with an IC 50 value of 4.5 μg/mL.
The genus Tanacetum contains 154 species that are mainly spread in the northern hemisphere of Europe, Asia and North America [1, 2] . Plant extracts of this genus have been associated with medicinal claims including antimicrobial [3] , anti-inflammatory [4] , immunomodulatory [5] , antioxidant [6] , antiviral [7] and antitumor [8] [9] [10] activities. The most abundant secondary metabolites isolated from Tanacetum species were found to be sesquiterpenoid lactones, the most common being parthenolide, which has been extensively studied for inhibition of various human cancer types including colorectal [11] , hepatoma [12] , gastric [13] , cholangiocarcinoma [14] , pancreatic [15] , bladder [16] and breast [17] . In addition, parthenolide was reported to induce rapid apoptosis in human glioblastoma cells without affecting the NF-κB pathway [18] .
The perennial herb, T. huronense (Nutt) (Lake Huron tansy), which belongs to the Asteraceae family, is native to the upper Midwest of North America, primarily in the dune areas of the Great Lakes, Maine and parts of Canada. Considering the anticancer potential of the Tanacetum genus, and the lack of information on compounds in T. huronense, we investigated the proliferation inhibitory activity of extracts and pure isolates from T. huronense against the human glioblastoma cell line U-87 MG.
Initially, cell proliferation inhibitory effects were evaluated for nhexane, ethyl acetate and methanolic extracts of T. huronense by the CCK8 (Dojindo) cell viability assay at a concentration of 50 μg/mL [18] . The ethyl acetate extract was the most active when compared with n-hexane and methanolic extracts. However, these extracts did not inhibit proliferation of human breast, stomach, colon, lung, prostate and CNS cell lines at 100 μg/mL concentrations. Therefore, a bioactivity-guided purification of the ethyl acetate extract was carried out and afforded six sesquiterpenoid lactones, tatridin A (1) [19] , 1-epi-tatridin B (2) [20] , tatridin B (3) [19] , tanacin (4) [21] , and two novel structural analogues of tanacin lactone (Figure 1 ). The structures of all isolates were elucidated by NMR spectroscopic and high-resolution mass spectrometric methods, and by comparison with previously reported data for compounds 1-4 [19] [20] [21] . further revealed the characteristic isovaleryl moiety in the C-6 position of the sesquiterpenoid lactone 6 ( Table 1) . All isolated compounds were further tested for human tumor cell antiproliferative activity on human colon, breast, stomach (AGS), prostate (DU145 and LNCaP) and CNS tumor cell lines in in vitro assays [22, 23] . However, none of the compounds inhibited proliferation of the cell lines tested at 5 μg/mL concentration.
In summary, this is the first report of the isolation of sesquiterpenoid lactones from this species, as well as its specific proliferation inhibition of human glioblastoma cells and by its pure isolates. In addition, the report of sesquiterpene lactones 5 and 6 is new. Treatment and cure of glioblastoma have only limited options at the moment. The activity profile of these sesquiterpene lactones isolated from T. huronense, especially tanacin (4) and its analogs against human brain tumor cell proliferation, suggest that these lactones could be further investigated as a template for the synthesis of promising therapeutic agents to treat and cure the fast growing human glioblastoma. 14) were maintained in Dulbecco's Modified Eagles Medium (DMEM; Thermoscientific) supplemented with 10% fetal calf serum (FCS; Thermoscientific) in 5% CO 2 at 37 0 C. Cells were seeded at 10,000 cells per well in 100 µL into 96 well tissue culture plates (Falcon). After 18-24 h cells were dosed with the indicated concentrations of the various compounds. Stock solutions were created by dissolving dried compounds at a concentration of 100 ppm in dimethyl sulfoxide (DMSO; Sigma-Aldrich). Dilutions were made in DMEM media supplemented with 10% FCS at twice the final concentration. One hundred µL of each dilution was added to the appropriate wells. After 48 h, 5 µL of CCK8 (Dojindo) was mixed with each well and the mixture incubated at 37 0 C for 1-2 h or until the controls reached an absorbance value of ~1 indicating that the reaction was at a maximal point where it was still in the linear range. Plates were read at 450 nm and values compared with controls that had only been dosed with DMSO. The DMSO treated wells at the concentrations used did not indicate any toxicity as compared to non-treated wells [18] .
Experimental

CCK8 (Dojindo) cell viability assay: U-87 MG cells (ATCC HTB-
MTT tumor cell proliferation inhibitory assay:
The extracts and compounds 1-6 were assayed for tumor cell growth inhibition at 100 and 5 µg/mL, respectively, as per the published method [22, 23] . Colon, breast, stomach (AGS), prostate (DU145 and LNCaP) and CNS human tumor cells were cultured in RPMI-1640 medium containing penicillin streptomycin and 10% fetal bovine serum (FBS). Aliquots of 100 µL of solutions containing respective test compounds were added to each well containing the test tumor cell line (100 µL). After incubation for 48 h, an aliquot (25 µL) of MTT solution was added and the plates incubated for 3 h at 37 0 C. The medium was removed from each well and cells treated with DMSO (200 µL). The plates were then shaken and optical density measured using a microplate reader at 570 nm. Adriamycin was used as positive control. The samples were assayed in triplicate and the experiment was repeated 3 times.
Supplementary data: 1 H, 1 H-1 H COSY spectra of 1; 1 H, 13 C, HMQC, HMBC, 1 H-1 H COSY spectra of 2; 1 H, 13 C spectra of 3; 1 H, 13 C and mass spectra of 4; 1 H, 13 C and mass spectra of 5; 1 H, 13 C and mass spectra of 6 are also available.
